Skip to content

BronchoPulmonary Dysplasia: an inflammatory disorder in children? The BPD PINK study

BronchoPulmonary Dysplasia: an inflammatory disorder in children? The BPD PINK study - BPD PINK study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57294
Enrollment
72
Registered
2024-05-07
Start date
2025-07-30
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchopulmonary dysplasia

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: BPD patients: - Diagnosis of severe BPD defined as oxygen need for >= 28 days from birth until 36 weeks postmenstrual age (PMA) AND need for >= 30% supplemental oxygen or dependence on continuous positive airway pressure, high flow nasal cannula or mechanical ventilation at 36 weeks PMA, following the 2001-National Institute of Health (NIH) definition. - Visiting the BPD follow up clinic at 8-10 years of age - Able to perform spirometry -Chest CT scan performed for clinical reasons - Written informed consent of both parent(s)/ caregiver(s)/ legal guardian as applicable Healthy controls: - Age 6-10 years - Sibs of BPD patient that will be included - Able to perform spirometry - Informed consent of both parent(s)/ caregiver(s)/ legal guardian(s) as applicable

Exclusion criteria

Exclusion criteria: BPD patients - respiratory diseases other than BPD, in particular clinical suspicion of  allergic asthma Control patients: - respiratory diseases, in particular clinical suspicion of allergic asthma - born < 37 weeks of gestation

Design outcomes

Primary

MeasureTime frame
Differences in markers of oxidative stress/ inflammation in exhaled breath between children with BPD and healthy controls.

Secondary

MeasureTime frame
- Correlations between markers of oxidative stress/ inflammation in exhaled breath and symptoms, lung function and chest CT scores.

Countries

Netherlands

Contacts

Public ContactM.W.H. Pijnenburg

Erasmus MC, Universitair Medisch Centrum Rotterdam

m.pijnenburg@erasmusmc.nl010 703626

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)